42291-0035 Lapatinib - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

42291-0035

Brand Name:

Lapatinib

Generic Name:

Lapatinib

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: LAPATINIB DITOSYLATE

Strength: 250.0

Unit: mg/1

Packages:

Code: 42291-0035-15

Description: 150 TABLET, FILM COATED in 1 BOTTLE (42291-035-15)

Effective Date: March 12, 2025

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

EGFR/HER2

Orphan Drug Designation:

Status:

In Use